Covid-19 nasal vaccine gets emergency use authorisation

Telangana

By Sumit Jha

November 29, 2022

The Central Drugs Standard Control Organisation has approved it under Restricted Use in Emergency Situation for booster doses.

Telangana

iNCOVACC has the double benefit of enabling faster development of variant-specific vaccines and easy nasal delivery.

Telangana

iNCOVACC is stable at 2-8° C for easy storage and distribution.

Telangana

Bharat Biotech said it has established large manufacturing capabilities at multiple sites across India.

Telangana

The vaccine was developed in partnership with Washington University, St Louis and funded in part by the Central government.

Telangana